imatinib mesylate has been researched along with Intestinal Obstruction in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adesunkanmi, AO; Lawal, AO; Mustapha, B; Ndegbu, CU; Odunafolabi, TA; Olasehinde, O; Olorunsola, IS | 1 |
| Barger, J; Kurtz, J; Ryan, K | 1 |
| Agud Fernández, M; Díaz Pedroche, C; Gómez-Martín, C; López López, F | 1 |
| Alaggio, R; Bisogno, G; Cecchetto, G; Cheng, L; d'Amore, ES; Dall'Igna, P; Martignoni, G; Sperlì, D | 1 |
| Gelderblom, H; Guchelaar, HJ; Oostendorp, RL; Schellens, JH; van Erp, NP | 1 |
1 review(s) available for imatinib mesylate and Intestinal Obstruction
| Article | Year |
|---|---|
Malignant perivascular epithelioid cell tumor in children: description of a case and review of the literature.
Topics: Abdominal Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biopsy; Child, Preschool; Combined Modality Therapy; Diagnostic Errors; Etoposide; Female; Humans; Imatinib Mesylate; Intestinal Obstruction; Ligaments; Liver Neoplasms; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Perivascular Epithelioid Cell Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Radiography; Sarcoma, Clear Cell; Sirolimus; X Chromosome Inactivation | 2012 |
4 other study(ies) available for imatinib mesylate and Intestinal Obstruction
| Article | Year |
|---|---|
Rectal gastrointestinal stromal tumor: an unusual presentation of an uncommon pathology (a case report).
Topics: Adult; Antigens, CD34; Antineoplastic Agents; Combined Modality Therapy; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Obstruction; Male; Proto-Oncogene Proteins c-kit; Rectal Neoplasms; Urinary Retention | 2021 |
A Metastatic Rectal Gastrointestinal Stromal Tumor to the Small Bowel Mesentery Treated with Neoadjuvant Imatinib and Debulking Surgery Followed by Low Anterior Resection.
Topics: Antineoplastic Agents; Combined Modality Therapy; Cytoreduction Surgical Procedures; Female; Gastrointestinal Stromal Tumors; Humans; Image-Guided Biopsy; Imatinib Mesylate; Intestinal Obstruction; Intestine, Small; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Rectal Neoplasms; Tomography, X-Ray Computed | 2017 |
Concurrent inflammatory bowel disease and gastrointestinal stromal tumor.
Topics: Aged, 80 and over; Combined Modality Therapy; Crohn Disease; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Immunosuppressive Agents; Intestinal Obstruction; Intestinal Pseudo-Obstruction; Jejunal Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Sunitinib | 2018 |
Is rectal administration an alternative route for imatinib?
Topics: Administration, Rectal; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Obstruction; Middle Aged; Neoplasm Metastasis; Piperazines; Pyrimidines | 2007 |